Jacob Thaysen - Agilent Technologies Insider

A -- USA Stock  

USD 63.85  0.30  0.47%

Mr. Jacob Thaysen was appointed as President of Agilent Life Sciences and Applied Markets Group of the Company. served as Senior Vice President, President Diagnostics and Genomics Group of Agilent Technologies, Inc., since November 2014. From October 2013 to November 2014 he served as Vice President and General Manager of the Diagnostics and Genomics business. Prior to that he served as Vice President and General Manager of the Genomics Solutions unit from January 2013 to October 2013. Before joining Agilent, he was Corporationrationrate Vice President of RD at Dako AS, a Danish diagnostics company from April 2011 to January 2013. His previous positions at Dako include Vice President, System Development, RD from March 2010 to April 2011, Vice President, Strategic Marketing from April 2009 to March 2010 and Vice President, Global Sales Operations from August 2008 to March 2009. Prior to Dako, Mr. Thaysen worked as a management consultant and Chief Technical Officer and founder of a hightech startup company.
Age: 41  President Since 2018      
408-345-8886  http://www.agilent.com

Jacob Thaysen Latest Insider Activity

Management Efficiency

The company has return on total asset of 6.97 % which means that for every 100 dollars spent on asset it generated profit of $6.97. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 5.27 % implying that it made 5.27 on every $100 invested by shareholders.
The company has accumulated 2.12 B in total debt with debt to equity ratio (D/E) of 45.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 3.25 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Showing few of many executives


Richard DoubledayDexCom
Jonathan WilcoxAmerican Renal Associates Holdi
Brian CaveneyLaboratory Corporation of Ameri
Birgit GirshickCharles River Laboratories Inte
Shawn SoderbergBio Rad Laboratories
Ronald HuttonBio Rad Laboratories
Emily HickeyCharles River Laboratories Inte
Mark BrecherLaboratory Corporation of Ameri
Michael CostaAmerican Renal Associates Holdi
John ListerDexCom
Shannon HallBio Rad Laboratories
Timothy ErnstBio Rad Laboratories
William BarboCharles River Laboratories Inte
Scott FrommerLaboratory Corporation of Ameri
Chris LinthwaiteFluidigm Corporation
Samuel EbertsLaboratory Corporation of Ameri
Jeffrey MoyDexCom
Jason BoucherAmerican Renal Associates Holdi
Brad KregerFluidigm Corporation
Andrew BaloDexCom
Nancy GillettCharles River Laboratories Inte

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in USA and traded on BATS Exchange. It employs 14000 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 14,000 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Heidi Kunz, Independent Director
Daniel Podolsky, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Hans Bishop, Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President; President - Diagnostics and Genomics Group
Samraat Raha, Senior Vice President - Strategy and Corporate Development
Mark Doak, Sr. VP and President of Agilent CrossLab Group
Paul Clark, Independent Director
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Director
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Robert Herbold, Independent Director
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Principal Accounting Officer, VP and Corporate Controller
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director

Stock Performance Indicators

Current Sentiment - A

Agilent Technologies Investor Sentiment
Most of Macroaxis users are presently bullish on Agilent Technologies. What is your sentiment towards investing in Agilent Technologies? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Agilent Technologies and Laboratory of America. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.